Taro Pharmaceutical Industries Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| NOVN | Novartis | Hold |
10
|
CHF91.11 | Buy/Sell | CHF105.00 | 18.12% | 9 | CHF185.90B |
| ALC | Alcon | Outperform |
8
|
CHF80.86 | Buy/Sell | CHF90.64 | 19.80% | 3 | CHF39.98B |
| VTRS | Viatris Inc | Hold |
8
|
$10.39 | Buy/Sell | $11.73 | 15.50% | 5 | $13.32B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.05 | Buy/Sell | £28.11 | 53.33% | 9 | £4.42B |
| PRGO | Perrigo Co PLC | Outperform |
16
|
$27.33 | Buy/Sell | $44.75 | 46.36% | 0 | $4.19B |
| PBH | Prestige Consumer Healthcare | Outperform |
16
|
$63.18 | Buy/Sell | $71.50 | 16.33% | 3 | $3.55B |
| BHC | Bausch Health Companies | Hold |
15
|
$6.20 | Buy/Sell | $9.50 | 53.23% | 5 | $2.55B |
| AMRX | Amneal Pharmaceuticals | Outperform |
16
|
$6.79 | Buy/Sell | $6.13 | 17.82% | 1 | $2.09B |
| VNDA | Vanda Pharmaceuticals | Outperform |
0
|
$4.98 | Buy/Sell | $4.25 | 4.62% | 0 | $311.94M |